The selling is modest relative to market cap and likely reflects routine portfolio diversification or tax planning. Monitor for any upcoming corporate events (earnings, pipeline updates) that could explain the timing, but no immediate bearish read-through is warranted.
Price Chart
Executive Summary
Two Eton Pharmaceuticals insiders (a director and the Chief Business Officer) sold a combined $2.44M in shares over a one-week window. The sales represent 0.14% of the company's $1.7B market cap — a modest amount that does not signal a material change in fundamentals.
Key Financial Metrics
Key Facts
- Total insider sales of $2.44M across 2 insiders (Director Paul V. Maier and CBO David Krempa)
- Sales represent approximately 0.14% of ETON's $1.7B market cap
- CBO Krempa sold 25,000 shares at $65.07 for $1.63M on August 24
- Director Maier sold 13,485 shares at $60.21 for $812K on August 28, alongside derivative exercises
- Analyst consensus is 90% bullish (2 Strong Buy, 7 Buy, 1 Hold)
Financial Impact
Insider sales of $2.44M represent 0.14% of market cap — modest and routine in size
Risk Factors
- Continued insider selling could weigh on sentiment if it accelerates
- CBO selling a large block may indicate reduced conviction in near-term prospects
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ETON-1788206887038 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $50.42 (−4.65%) |
Oct 6, 2026 20d ago | 144 | $54.88 | awaiting T+60 | — | $50.42 (−8.13%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $50.42 (−14.80%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $50.42 (−16.56%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $50.42 (−16.58%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $50.42 (+20.03%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $50.42 (+17.99%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $50.42 (+9.68%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $50.42 (+9.68%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $50.42 (+10.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers